迈普医学：关于医疗器械进入临床试验的公告

Group 1 - The core point of the article is that Maipu Medical has announced that its research project "Absorbable Regenerative Oxidized Cellulose Hemostatic Granules" has officially entered the clinical trial phase [2] Group 2 - The announcement was made on the evening of September 16 [2] - This development indicates a significant step forward in the company's product pipeline and potential market offerings [2] - The clinical trial phase is crucial for the validation and eventual commercialization of the product [2]